KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2017 - 2025)

Sarepta Therapeutics has reported Asset Utilization Ratio over the past 11 years, most recently at 0.64 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 27.74% year-over-year to 0.64; the TTM value through Dec 2025 reached 0.64, up 27.74%, while the annual FY2025 figure was 0.6, 14.23% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.64 at Sarepta Therapeutics, down from 0.67 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.69 in Q2 2025 and troughed at 0.15 in Q3 2022.
  • A 5-year average of 0.4 and a median of 0.35 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 35.37% in 2022 and later skyrocketed 144.1% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.24 in 2021, then soared by 36.01% to 0.33 in 2022, then soared by 36.7% to 0.45 in 2023, then grew by 11.97% to 0.5 in 2024, then increased by 27.74% to 0.64 in 2025.
  • Business Quant data shows Asset Utilization Ratio for SRPT at 0.64 in Q4 2025, 0.67 in Q3 2025, and 0.69 in Q2 2025.